These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38293518)

  • 1. Enhanced gastric residence time of acyclovir by floating raft formulation using box-behnken design.
    Munusamy R; Shanmugasundharam S
    Heliyon; 2024 Jan; 10(2):e24301. PubMed ID: 38293518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved gastric residence time of famotidine by raft-forming drug delivery system using DOE.
    Munusamy R; Shanmugasundharam S
    Int J Immunopathol Pharmacol; 2024; 38():3946320241249429. PubMed ID: 38721971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
    Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
    Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori.
    Abou Youssef NA; Kassem AA; El-Massik MA; Boraie NA
    Int J Pharm; 2015; 486(1-2):297-305. PubMed ID: 25843757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated Lipid Polymeric Nanoparticle-Encapsulated Acyclovir for In Vitro Controlled Release and Ex Vivo Gut Sac Permeation.
    Mahmood S; Kiong KC; Tham CS; Chien TC; Hilles AR; Venugopal JR
    AAPS PharmSciTech; 2020 Oct; 21(7):285. PubMed ID: 33057878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH responsive alginate polymeric rafts for controlled drug release by using box behnken response surface design.
    Abbas G; Hanif M; Khan MA
    Des Monomers Polym; 2017; 20(1):1-9. PubMed ID: 29491774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
    Dey S; Mazumder B; Chattopadhyay S; Das MK; Sinha S; Ganguly S; De K; Mishra M
    Int J Biol Macromol; 2014 Apr; 65():346-56. PubMed ID: 24472506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, optimization, and evaluation of raft-forming formulations containing Nizatidine.
    Darwish MKM; Abu El-Enin ASM; Mohammed KHA
    Drug Dev Ind Pharm; 2019 Apr; 45(4):651-663. PubMed ID: 30638411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Assessment of Acyclovir Gel Plaster Containing Sponge Spicules.
    Shan S; Hu J; Zheng Z; Gui S; Long Y; Wu D; He N
    J Pharm Sci; 2023 Nov; 112(11):2879-2890. PubMed ID: 37331627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, Optimization and Evaluation of Organogel for Topical Delivery of Acyclovir.
    Bonde S; Mavani N; Bonde C
    Curr Drug Deliv; 2018; 15(3):397-405. PubMed ID: 29034838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development of ambroxol hydrochloride soft gel with application of statistical experimental design and response surface methodology.
    Dabhi M; Gohel M; Parikh R; Sheth N; Nagori S
    PDA J Pharm Sci Technol; 2011; 65(1):20-31. PubMed ID: 21414937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Quality by Design Approach of Metronidazole Bigel and Assessment of Antimicrobial Study Utilizing Box-behnken Design.
    Roy H; Maddela S; Munagala A; Rahaman SA; Nandi S
    Comb Chem High Throughput Screen; 2021; 24(10):1628-1643. PubMed ID: 33380293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of gastroretentive floating tablets of acyclovir.
    Garg R; Gupta GD
    Curr Drug Deliv; 2009 Oct; 6(5):437-43. PubMed ID: 19751200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and pharmacokinetic evaluation of alginate-pectin polymeric rafts forming tablets using box behnken design.
    Abbas G; Hanif M
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2026-2037. PubMed ID: 30084289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
    El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
    Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug.
    Abouelatta SM; Aboelwafa AA; El-Gazayerly ON
    Drug Deliv; 2018 Nov; 25(1):1161-1174. PubMed ID: 29792353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of acyclovir oral tablets based on gastroretention technology: factorial design analysis and physicochemical characterization studies.
    El Gamal SS; Naggar VF; Allam AN
    Drug Dev Ind Pharm; 2011 Jul; 37(7):855-67. PubMed ID: 21401342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment.
    Kerdsakundee N; Mahattanadul S; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2015 Aug; 94():513-20. PubMed ID: 26143367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and in vitro evaluation of floating drug delivery system for an antipsychotic agent: a technical report.
    Kar M; Reddy MS
    PDA J Pharm Sci Technol; 2006; 60(6):389-94. PubMed ID: 17260904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.